DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo

Information source: Pfizer
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Osteoporosis

Intervention: Forteo (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Pfizer

Official(s) and/or principal investigator(s):
Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer

Overall contact:
Pfizer CT.gov Call Center, Phone: 1-800-718-1021

Summary

This methodology trial will be conducted in patients with osteoporosis and will measure the changes in bone quality parameters, micro- and macroarchitecture, bone biomarkers and bone density following therapy with the approved drug, Forteo.

Clinical Details

Official title: A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Recombinant Human Parathyroid Hormone, Pth (Forteo)

Study design: Other, Non-Randomized, Open Label, Single Group Assignment

Primary outcome: Changes in bone quality parameters (micro- and macroarchitecture) in osteoporotic postmenopausal women following 12 months of therapy with Forteo

Secondary outcome: Changes in BMD and bone biomarkers following 12 months of therapy with Forteo

Eligibility

Minimum age: 55 Years. Maximum age: 70 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Postmenopausal women with osteoporosis

Exclusion Criteria:

- Any therapies or products affecting bone turnover within 12 months of Screening.

- Bisphosphonate treatment >1 month in total duration at any time in the past.

- In addition, patients must be bisphosphonate-treatment-free for at least 12 months

prior to Screening.

Locations and Contacts

Pfizer CT.gov Call Center, Phone: 1-800-718-1021

Pfizer Investigational Site, Buenos Aires C1055AAK, Argentina; Recruiting

Pfizer Investigational Site, Buenos Aires C1428AQK, Argentina; Recruiting

Pfizer Investigational Site, Capital Federal - Buenos Aires C1012AAP, Argentina; Recruiting

Additional Information

To obtain contact information for a study center near you, click here.

Starting date: December 2006
Ending date: May 2008
Last updated: April 9, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012